Last reviewed · How we verify
NCT05568602
Appropriate Limit Value for 1 mg DST in Patients With Chronic Renal Failure
trial testing Dexamethasone suppression test in Cushing Syndrome in 1,034 participants. Completed in 1 August 2021.
1 June 2021
Quick facts
| Lead sponsor | Marmara University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,034 |
| Start date | 1 June 2020 |
| Primary completion | 1 June 2021 |
| Estimated completion | 1 August 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Dexamethasone suppression test
Conditions studied
- Cushing Syndrome — all drugs for Cushing Syndrome →
Sponsor
Marmara University
Who can join
Adults 18 to 80, any sex, with Cushing Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, we aimed to determine a specific cut-off value for 1mg DST to prevent false positivity usually seen in CRF patients according to the standard cut-off value of 1.8 mcg/dl.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hair cortisol and changes in cortisol dynamics in chronic kidney disease.
Boswell L, Vega-Beyhart A, Blasco M, Quintana LF, et al · · 2024 · cited 6× · PMID 38638132 · DOI 10.3389/fendo.2024.1282564
Verify or expand the search:
- PubMed search for NCT05568602
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexamethasone suppression test
Trials testing the same drug.
- NCT06190158 — Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease · EARLY_PHASE1 · recruiting
- NCT05766085 — Cortisol Secretion, Sensitivity and Activity and Hypertension · unknown
Other recruiting trials for Cushing Syndrome
Currently open trials in the same condition.
- NCT07168122 — Establishment and Clinical Application of Reference Intervals of Salivary Cortisol · recruiting
- NCT06635629 — Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome · Phase 2 · recruiting
- NCT06573723 — Institutional Registry of Rare Diseases · recruiting
- NCT06250699 — A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery · NA · recruiting
- NCT05911620 — Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hyperco · NA · recruiting
Other Marmara University trials
Trials by the same sponsor.
- NCT07533734 — The Effects of an Augmented Reality-Based Mirror Therapy System in Patients With Stroke · NA · not yet recruiting
- NCT07474181 — Simulation-Based Training for Urinary Catheterization Skills in Nursing Students · NA · not yet recruiting
- NCT07486349 — Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery · NA · not yet recruiting
- NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke · recruiting
- NCT07468097 — The Impact of Metabolic Status on Pain and Central Sensitization in Women With Lipedema: A Cross-Sectional Observational · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05568602 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Marmara University
- Last refreshed: 5 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05568602.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing